Neuphoria Therapeutics (NEUP) Price to Book (2022 - 2026)

Neuphoria Therapeutics (NEUP) has reported Price to Book for 5 consecutive years, with 17.24 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Price to Book fell 37.57% year-over-year to 17.24 in Q1 2026; TTM through Mar 2026 was 17.24, a 37.57% decrease from a year earlier, with the FY2025 full-year figure at 46.29, down 28.97% from the prior year.
• Price to Book was 17.24 for Q1 2026 at Neuphoria Therapeutics, up from 16.29 in the prior quarter.
• Over five years, Price to Book peaked at 234.45 in Q3 2023 and troughed at 16.29 in Q4 2025.
• A 5-year average of 90.3 and a median of 65.57 in 2024 frame the typical range for Price to Book.
• Across the five-year window, Price to Book tumbled 83.58% in 2024 and surged 205.27% in 2025, its largest moves.
• Over 5 years, Price to Book stood at 232.05 in 2022, then tumbled by 51.07% to 113.55 in 2023, then tumbled by 72.61% to 31.1 in 2024, then tumbled by 47.64% to 16.29 in 2025, then climbed by 5.88% to 17.24 in 2026.
• The last three Price to Book figures came in at 17.24 (Q1 2026), 16.29 (Q4 2025), and 117.48 (Q3 2025), per Business Quant data.